Comparison · not a ranking
AOD 9604 compared with Tesamorelin
AOD 9604 and Tesamorelin are separate catalogue items. They are not interchangeable.A CoA for every lot; each vial carries a printed lot number that matches it. Request yours and we email it within 2 hours. Research use only. Not a medicine.
Last verified 9 Nov 2026. UK prices checked daily.
AOD 9604 and Tesamorelin are two distinct catalogue compounds. AOD 9604 is a 16-residue peptide, while Tesamorelin is a 44-residue peptide. AOD 9604: C78H123N23O23S2, 1815.1 g/mol, CAS 221231-10-3. Tesamorelin: C221H366N72O67S, 5136.0 g/mol, CAS 218949-48-5. In short, their molecular weights differ by about 3320.9 g/mol; their sequences differ in length (16 versus 44 residues). Each has its own reference record, which lists the source for every figure above. Sable Peptides, a UK supplier operating since 2019, lists both as lyophilised research material; every vial carries a lot number and a certificate of analysis exists for every lot — request yours at /coa-request and we email it within 2 hours. This intro compares identity only and ranks neither compound. Research use only. Not a medicine. Not for human or veterinary use.
Sources: pubchem.ncbi.nlm.nih.gov · pubchem.ncbi.nlm.nih.gov
AOD 9604 and Tesamorelin are two records in the Sable Peptides catalogue at https://www.sablepeptides.co.uk/versus/aod-9604/tesamorelin. These prices are both Sable catalogue prices. They are not a comparison with another shop. This page does not rank either compound. Each page shows the catalogue price. A market comparison appears only when an exact, current, approved listing for that size is on record. Only a row with the same amount is a like-for-like price.
Research use only. Not a medicine. Not for human or veterinary use. Disclaimer
| Amount | AOD 9604 | Tesamorelin |
|---|---|---|
| 2 mg | £14.29 | £23.00 |
| 5 mg | £18.99 | £15.00 |
| 10 mg | £29.00 | £28.98 |
Reference facts
| Fact | AOD 9604 | Tesamorelin |
|---|---|---|
| Molecular weight | 1815.1 g/mol | 5136.0 g/mol |
| Molecular formula | C78H123N23O23S2 | C221H366N72O67S |
| CAS number | 221231-10-3 | 218949-48-5 |
| Compound class | peptide | peptide |
Sources: pubchem.ncbi.nlm.nih.gov, pubchem.ncbi.nlm.nih.gov Verified 2026-11-09
- Category
- AOD 9604Repair
- TesamorelinGH axis
- Research use only
- AOD 9604Yes
- TesamorelinYes
- Vials
- AOD 96043
- Tesamorelin4
- Record
- AOD 9604aod-9604
- Tesamorelintesamorelin
Questions this page answers
- How does AOD 9604 compare with Tesamorelin?
- Same vial amounts are shown side by side with each catalogue price. Different amounts are not treated as the same price. No effect is compared, and another seller is not compared.
- Which is better?
- This page does not say. It does not rank safety, strength, or effect.
- What is the lowest catalogue price per mg for AOD 9604 and Tesamorelin?
- AOD 9604: £2.90/mg on the 10 mg vial (£29.00). Tesamorelin: £2.90/mg on the 10 mg vial (£28.98). Different compounds; this is a catalogue price fact, not a ranking.
- How many vial sizes are listed for each?
- AOD 9604: 2 mg, 5 mg, 10 mg. Tesamorelin: 2 mg, 5 mg, 10 mg, 20 mg.
Both compounds
Related research
In-depth comparison
Sable research note. Updated 2026-10-10. Research use only.
Short answer
AOD 9604 and Tesamorelin are different compounds. AOD 9604 is a modified growth-hormone fragment peptide; Tesamorelin is a GHRH analogue. By PubChem's computed values, Tesamorelin (5136 g/mol) is about 2.8 times the mass of AOD 9604 (1815.1 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.
At a glance
| AOD 9604 | Tesamorelin | |
|---|---|---|
| Class | modified growth-hormone fragment peptide | GHRH analogue |
| Formula (PubChem) | C78H123N23O23S2 | C221H366N72O67S |
| Molecular weight (PubChem, g/mol) | 1815.1 | 5136 |
| PubChem CID | 71300630 | 16137828 |
| Sable form | freeze-dried powder | freeze-dried powder |
Structure
AOD 9604 is a modified fragment of human growth hormone residues 177-191, with an added N-terminal tyrosine (16 residues, one disulfide bridge). PubChem CID 71300630 lists the formula C78H123N23O23S2 and a computed molecular weight of 1815.1 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/71300630).
Tesamorelin is full-length GHRH(1-44)-NH2 carrying an N-terminal trans-3-hexenoyl group. PubChem CID 16137828 lists the formula C221H366N72O67S and a computed molecular weight of 5136 g/mol (https://pubchem.ncbi.nlm.nih.gov/compound/16137828).
Both are peptides, so the meaningful structural differences are sequence, length and modifications rather than chemical category. Differences in residue count, terminal capping (acetylation or amidation), non-natural amino acids and lipid side chains all change molecular weight, solubility and how a compound behaves in an assay. Matching like with like at the structural level is the first step before any comparison of experimental results.
Molecular weight in context
On PubChem's computed figures, AOD 9604 is a mid-sized peptide (1,000 to 3,000 g/mol) and Tesamorelin is a large peptide (over 3,000 g/mol). The difference is 3,320.9 g/mol.
Molecular weight matters in practice for three reasons. First, one milligram of a lighter compound contains more molecules than one milligram of a heavier one, so equal milligram amounts are not equal molar amounts. Second, the expected mass is what identity testing checks against: mass spectrometry on a certificate of analysis should report a value consistent with the formula. Third, salt forms (for example acetate or TFA counter-ions) and metal complexes add mass that a free-base figure does not show, so a certificate may legitimately quote a slightly different value from a database entry.
Class and research context
AOD 9604: studied as a growth-hormone C-terminal fragment analogue.
Tesamorelin: a GHRH-receptor agonist; also the active substance of a licensed medicine in some countries (Sable does not sell that medicine).
These descriptions summarise how each compound is characterised in the published literature and in chemical databases. They are not claims about effects in people, and Sable gives no administration or medical-use information for either compound. Readers who need mechanism detail should go to the primary sources and the PubChem literature sections linked below.
How to compare them fairly
- Compare identity first: formula, sequence and expected mass, then purity.
- Compare amounts only at the same milligram size, remembering that equal milligrams are not equal moles.
- Ask for the certificate of analysis for the specific batch. At Sable, every vial is released at ≥99% purity by HPLC with identity checked against the expected mass, and certificates are available for every lot.
- Treat a search pairing as a navigation habit, not as evidence that two compounds do the same thing.
Sable listings
Vial sizes as listed on 2026-10-10. Each product page carries the current catalogue details.
AOD 9604 (compound guide: https://www.sablepeptides.co.uk/aod-9604-uk): - AOD 9604 2 mg: https://www.sablepeptides.co.uk/product/aod-9604-2mg - AOD 9604 5 mg: https://www.sablepeptides.co.uk/product/aod-9604-5mg - AOD 9604 10 mg: https://www.sablepeptides.co.uk/product/aod-9604-10mg
Tesamorelin (compound guide: https://www.sablepeptides.co.uk/tesamorelin-uk): - Tesamorelin 2 mg: https://www.sablepeptides.co.uk/product/tesamorelin-2mg - Tesamorelin 5 mg: https://www.sablepeptides.co.uk/product/tesamorelin-5mg - Tesamorelin 10 mg: https://www.sablepeptides.co.uk/product/tesamorelin-10mg - Tesamorelin 20 mg: https://www.sablepeptides.co.uk/product/tesamorelin-20mg
Peptide vials contain freeze-dried powder only; bacteriostatic water is listed separately. Research use only. Not a medicine. Not for human or veterinary use.
Sources
- PubChem, AOD 9604: https://pubchem.ncbi.nlm.nih.gov/compound/71300630
- PubChem, Tesamorelin: https://pubchem.ncbi.nlm.nih.gov/compound/16137828
- Sable price index and methodology: https://www.sablepeptides.co.uk/pricing/methodology
- Sable quality and certificate requests: https://www.sablepeptides.co.uk/quality
Comparison questions
What is the difference between AOD 9604 and Tesamorelin?
AOD 9604 and Tesamorelin are different compounds. AOD 9604 is a modified growth-hormone fragment peptide; Tesamorelin is a GHRH analogue. By PubChem's computed values, Tesamorelin (5136 g/mol) is about 2.8 times the mass of AOD 9604 (1815.1 g/mol). Sable lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.
What are the molecular weights of AOD 9604 and Tesamorelin?
AOD 9604: 1815.1 g/mol (PubChem CID 71300630); Tesamorelin: 5136 g/mol (PubChem CID 16137828).
Are these sold for use in people?
No. Both are laboratory research material only: not medicines, and not for use in people or animals. No administration or medical-use information is provided.